Alprazolam and Ibuprofen in the Treatment of Fibromyalgia-Report of a Double-Blind Placebo-Controlled Study

References

• Felson DT, Goldenberg DL: The natural history of fibromyalgia. Arthritis Rheum 29: 1522–1526, 1986.
   PubMed Web of Science ®Google Scholar
• Goldenberg DL: Fibromyalgia syndrome. An emerging but controversial condition. JAMA 257: 2782–2787, 1987.
   Google Scholar
• Wolfe F, Hawley DJ, Cathey MA, Caro X, Russell IJ: Fibrositis: symp-tom frequency and criteria for diagnosis. An evaluation of 291 rheumatic dis-ease patients and 58 normal individuals. J Rheumatol 12: 1159–1163, 1985.
   Google Scholar
• Moldofslcy H, Scarisbrick P, England R, Smythe H: Musculoskeletal symp-toms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37: 341–351, 1975.
   PubMed Web of Science ®Google Scholar
• Payne TC, Leavitt F, Garron DC, Katz RS, Golden HE, Glickman PB, Van-derplate C: Fibrositis and psychologic disturbance. Arthritis Rheum 25: 213–217, 1982.
   PubMed Web of Science ®Google Scholar
• Clark S, Campbell SM, Forehand ME, Tindall EA, Bennett RM: Clinical characteristics of fibrositis. 1–1. A "blinded," controlled study using standard psy-chological tests. Arthritis Rheum 28: 132–137, 1985.
   Google Scholar
• Tavoni A, Vitali C, Bombardieri S, Pasero G: Evaluation of S-adenosytme-thionine in primary fibromyalgia. A double-blind crossover study. Am J Med 83 [Suppl 5AJ: 107–110, 1987.
   Google Scholar
• Yunus MB, Masi AT, Aldag JC: Short term effects of ibuprofen in prftnary fibromyalgia syndrome: a double-blind, placebo controlled trial. J Rheumatol 16: 527–532, 1989.
   PubMed Web of Science ®Google Scholar
• Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG: Fibromyal-gia and major affective disorder: a controlled phenomenology and family history study. Am .1 Psychiatry 142: 441–446, 1985.
   Google Scholar
• Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 16 [Suppl 19]: 140–143, 1989.
   Google Scholar
• Clark S, Tindall E, Bennett RM: A double blind crossover trial of predni-sone versus placebo in the treatment of fibrositis. J Rheumatol 12: 980–983, 1985.
   PubMed Web of Science ®Google Scholar
• Bibolotti E, Borghi C, Pasculli E, Regoli F, Tavoni A, Baroni L, Castrogio-vanni P, Pasero G: The management of fibrositis. A double-blind comparison of maprotiline [LudiomilR1, chlorimipramine and placebo. Clinical Trials Journal 23: 269–280, 1986.
   Google Scholar
• Carette S, McCain GA, Bell DA, Fam AG: Evaluation of arnitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 29: 655–659, 1986.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrosi-tis. A double-blind controlled study. Arthritis Rheum 31: 1535–1542, 1988.
   PubMed Web of Science ®Google Scholar
• Jacobs JWG, Rasker JJ, Van Riel PLCM, Gribnau FWJ, Van de Putte LBA: Behandeling met Rheumajecta en Vasolastine van primaire fibromyalgie; resulta- ten van een gerandorniseerd, placebo-gecontroleerd, dubbelblind onderzoek. Ned Tijdschr Geneeskd 134: 693–697, 1990.
   PubMedGoogle Scholar
• Caruso I, Sarzi Puttini PC, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 15:154–159, 1987.
   PubMed Web of Science ®Google Scholar
• Goldenberg DL, Felson DT, Dinemtan H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthri-tis Rheum 29: 1371–1377, 1986.
   PubMed Web of Science ®Google Scholar
• Le Gallez P, Reeve FBA, Crawley MA, Bird HA: A double-blind compari-son of ibuprofen, placebo and ibuprofen with meptazinol in soft tissue rheuma-tism. Curr Med Res Opin 10: 663–667, 1988.
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Abraharnsen A, Forre 0, Kass E: Treatment of fibromyalgia [fi-brositis syndrome]: a parallel double blind trial with carisoprodol, paracetamol and caffeine [Somadril compR1 versus placebo. Clin Rheumatol 8: 245–250, 1989.
   PubMed Web of Science ®Google Scholar
• Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 18: 201–209, 1990.
   PubMed Web of Science ®Google Scholar
• Russell U, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treat-ment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum 34: 552–560, 1991.
   PubMed Web of Science ®Google Scholar
• Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM: Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis Rheum 26: 817–824, 1983.
   Google Scholar
• Dawson GW, Jue SG, Brogden RN: Alprazolam. A review of its pharma-codynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27: 132–147, 1984.
   Google Scholar
• Rickels K, Chung HR, Csanalosi 113, Hurowitz AM, London J, Wiseman K, Kaplan M, Amsterdam JD: Alprazolam, diazepam, imiprarnine, and placebo in outpatients with major depression. Arch Gen Psychiatry 44: 862–866, 1987.
   PubMed Web of Science ®Google Scholar
• Yunus M, Masi AT, Calabro ii, Miller KA, Feigenbaum SL: Primary fibro-myalgia [fibrositis]: clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11: 151–171, 1981.
   PubMed Web of Science ®Google Scholar
• McCarty DJ, Gatter RA, Phelps P: A dolorimeter for quantification of ar-ticular tenderness. Arthritis Rheum 8: 551–559, 1965.
   PubMed Web of Science ®Google Scholar
• Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62, 1960.
   PubMed Web of Science ®Google Scholar
• Beck AT, Beamesderfer A: Assessment of depression. Mod Probl Pharma-copsychiatry 7: 151–169, 1974.
   PubMedGoogle Scholar
• Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35: 837–1978.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 35: 773–782, 1982.
   Google Scholar
• Hamilton M: Diagnosis and ratings of anxiety. Br J Psychiatry 3 [Special Issue]: 76–79, 1969.
   Google Scholar